A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Merck Sharp & Dohme LLC
Second Affiliated Hospital, School of Medicine, Zhejiang University
ADC Therapeutics S.A.
Ikena Oncology
OHSU Knight Cancer Institute
Fate Therapeutics
Northwestern University
Western Regional Medical Center